Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A9ZQ
|
|||
| Former ID |
DNC005642
|
|||
| Drug Name |
(3-Phenoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine
|
|||
| Synonyms |
N-(3-phenoxyphenyl)-5-phenyl-1,3-oxazol-2-amine; 2-Anilino-5-aryloxazole 11; AC1NS7R8; CHEMBL191626
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H16N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC(=CC=C3)OC4=CC=CC=C4
|
|||
| InChI |
1S/C21H16N2O2/c1-3-8-16(9-4-1)20-15-22-21(25-20)23-17-10-7-13-19(14-17)24-18-11-5-2-6-12-18/h1-15H,(H,22,23)
|
|||
| InChIKey |
JTIZQZSOCSALNJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.